Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer
March 02, 2020 05:30 ET
|
Immunicum AB
Press Release 2 March 2020 Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer Immunicum AB (publ) announces that the company's CFO, Michaela Gertz,...
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
February 27, 2020 07:30 ET
|
Adaptimmune Therapeutics plc
- Compelling data in synovial sarcoma in the Phase 1 trial, and continued momentum in the Phase 2 SPEARHEAD-1 trial with goal to launch ADP‑A2M4 for sarcoma in 2022 - - Encouraging...
Immunicum AB (publ) Bokslutskommuniké 2019
February 18, 2020 02:00 ET
|
Immunicum AB
Pressmeddelande 18 februari 2020 Immunicum AB (publ) Bokslutskommuniké 2019 OKTOBER – DECEMBER I SAMMANDRAG Nettoomsättning för kvartalet uppgick till - KSEK (- KSEK).Kvartalets resultat uppgick...
Immunicum AB (publ) Year-End Report 2019
February 18, 2020 02:00 ET
|
Immunicum AB
Press Release 18 February 2020 Immunicum AB (publ) Year-End Report 2019 October – December in Summary Net sales for the period amounted to KSEK - (-).Result for the quarter amounted to KSEK...
Taconic Biosciences Expands Humanized Mouse Model Production
February 14, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now...
Fluidigm to Participate in Upcoming Investor Conferences
February 12, 2020 16:05 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Establishes Center of Excellence at NCI-Designated Comprehensive Cancer Center to Advance Imaging Mass Cytometry
February 10, 2020 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Immunicum AB (publ) meddelar uppdaterade data från MERECA-studien med ilixadencel i njurcancer vid ASCO-SITC Clinical Immuno-Oncology-symposiet
February 06, 2020 13:40 ET
|
Immunicum AB
Pressmeddelande 6 februari 2020 Immunicum AB (publ) meddelar uppdaterade data från MERECA-studien med ilixadencel i njurcancer vid ASCO-SITC Clinical Immuno-Oncology-symposiet -- Data från december...
Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium
February 06, 2020 13:40 ET
|
Immunicum AB
Press Release 6 February 2020 Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium --...
Immunicum AB (publ) meddelar att abstrakten inför ASCO-SITC Clinical Immuno-Oncology Symposium publicerats
February 03, 2020 17:00 ET
|
Immunicum AB
Pressmeddelande 3 februari 2020 Immunicum AB (publ) meddelar att abstrakten inför ASCO-SITC Clinical Immuno-Oncology Symposium publicerats Immunicum AB (publ; IMMU.ST) meddelade i dag att...